PNC Financial Services Group
BHVN

PNC Financial Services Group’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

PNC Financial Services Group’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-584
Closed -$88K – 4945
2022
Q3 		$88K Buy
584
+104
+22% +$15.4K ﹤0.01% 2631
2022
Q2 		$71K Sell
480
-255
-35% -$32.6K ﹤0.01% 2791
2022
Q1 		$88K Sell
735
-232
-24% -$28.9K ﹤0.01% 2791
2021
Q4 		$133K Buy
967
+159
+20% +$20.2K ﹤0.01% 2500
2021
Q3 		$112K Buy
808
+72
+10% +$8.99K ﹤0.01% 2576
2021
Q2 		$71K Sell
736
-109
-13% -$8.85K ﹤0.01% 2859
2021
Q1 		$57K Sell
845
-831
-50% -$67.2K ﹤0.01% 2910
2020
Q4 		$144K Sell
1,676
-65
-4% -$5.51K ﹤0.01% 2278
2020
Q3 		$114K Buy
1,741
+26
+2% +$1.7K ﹤0.01% 2249
2020
Q2 		$124K Buy
1,715
+1,688
+6,252% +$89.8K ﹤0.01% 2206
2020
Q1 		$1K Buy
+27
New +$1.24K ﹤0.01% 3867
2019
Q4 		– Sell
-86
Closed -$4K – 4256
2019
Q3 		$4K Sell
86
-13
-13% -$549 ﹤0.01% 3796
2019
Q2 		$5K Buy
+99
New +$5.58K ﹤0.01% 3763
2018
Q2 		– Sell
-26
Closed – – 4477
2018
Q1 		$0 Hold
26
– – ﹤0.01% 4440
2017
Q4 		$0 Buy
26
+2
+8% +$55 ﹤0.01% 4421
2017
Q3 		$1K Sell
24
-16
-40% -$485 ﹤0.01% 4122
2017
Q2 		$1K Buy
+40
New +$921 ﹤0.01% 4142

Other funds holding BHVN

LIP
Liontrust Investment Partners London, United Kingdom $5.86B AUM 23.75% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MSCM
McElhenny Sheffield Capital Management Dallas, Texas $404M AUM 19.8% 1-Year Est. Return

PNC Financial Services Group's BHVN Position: Q4 2022 in Review

PNC Financial Services Group sold out of Biohaven Pharmaceutical Holding Company Ltd. (BHVN) in Q4 2022, closing a stake of 584 shares — an estimated $88K sold.

PNC Financial Services Group first reported a position in BHVN in Q2 2017 and held it in 17 quarters. The position peaked at $144K in Q4 2020. 7 funds tracked by Wall St. Rank hold BHVN as of Q4 2022.

  • PNC Financial Services Group reported no remaining Biohaven Pharmaceutical Holding Company Ltd. position as of Q4 2022 after selling out during the quarter.
  • PNC Financial Services Group sold 584 Biohaven Pharmaceutical Holding Company Ltd. shares in Q4 2022, an estimated $88K.
  • PNC Financial Services Group first reported a position in Biohaven Pharmaceutical Holding Company Ltd. in Q2 2017 and held it in 17 quarters.
  • PNC Financial Services Group's Biohaven Pharmaceutical Holding Company Ltd. position peaked at $144K in Q4 2020.
  • 7 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q4 2022.

Based on PNC Financial Services Group's 13F filing for Q4 2022, filed 10 Feb 2023.